Welcome to the Journal


Stem Cell Research and Regenerative Medicine as a field of study has been gaining great significance with the increasing financial burden to the nations of the globe. Cardio vascular diseases are the number one reason for deaths globally. Stem Cell Research and Regenerative Medicine is a scholarly open access journal that offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field.

Since cardiovascular diseases can be prevented by addressing behavioural risk factors Stem Cell Research and Regenerative Medicine journal includes wide areas of studies in this field by including apical hypertrophic cardiomyopathy, coronary artery ectasia, fetal heart calcification, chronic arterial insufficiency, cardiovascular disease and its association with cancer, peri-arrest period, complications after heart surgery, early repolarization symptoms, coronary arteritis, inflammatory vascular disease, inflammatory cardiomyopathy, systolic pressure variation, left atrium enlargement, and ventricular septal defect (VSD).

The journal offers thoroughly reviewed original research as research articles, review articles, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to association of abiotrophia species with heart problem, heart and blood vessel disorders, myocardial infarction (heart attack), issues of cardiac arrest, stroke, techniques and procedure used in stent implantation, anticoagulant drugs (blood thinners), basic research in heart structure and functions and other medical conditions and associated treatments etc.

The journal also focuses on the latest therapeutic efforts such as application of cardiac progenitor cells, angioplasty, percutaneous coronary intervention (PCI) such as percutaneous transluminal coronary angioplasty (PTCA), and other stent implantation, anticoagulant drugs (blood thinners), therapy after open heart surgery, use of ventricular assist device.

Submit your manuscripts through tracking System: Online Submission System or directly accepted by Editorial Office at manuscript@openaccessjournals.com

Stem Cell Research and Regenerative Medicine is listed in the quality indexing sites such as Scopus, EMBASE/Excerpta Medica to increase visibility and discoverability.

Kindly visit the Author for Guidelines page for more information and ensure that you accept all the Terms and Conditio of the Journal and ensure to check the APC(s)charges before the article been submitted to the Journal.

Fast Editorial Execution and Review Process (FEE-Review Process):

Stem Cell Research and Regenerative Medicine is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

Cialis was originally manufactured by Eli Lilly under patent but today there are plenty of generic alternatives on the general market which means wider availability. We offer to buy Generic Cialis - one of the most popular alternatives in the US with the same active ingridient.
*2023 Journal Impact Factor was established by dividing the number of articles published in 2021 and 2022 with the number of times they are cited in 2023 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2021 and 2022, and 'Y' is the number of times these articles were cited in indexed journals during 2023 then, journal impact factor = Y/X

h-index

Articles published in Stem Cell Research and Regenerative Medicine have been cited by esteemed scholars and scientists all around the world. Stem Cell Research and Regenerative Medicine has got h-index 4 , which means every article in Stem Cell Research and Regenerative Medicine has got 4 average citations.


Recently Published Articles


Relevant Topics

Awards Nomination 20+ Million Readerbase

Select your language of interest to view the total content in your interested language


Google Scholar citation report
Citations : 32

Stem Cell Research and Regenerative Medicine received 32 citations as per Google Scholar report


Stem Cell Research and Regenerative Medicine peer review process verified at publons

Indexed In

flyer